Scissortail Wealth Management’s AbbVie ABBV Stock Holding History

Scissortail Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.21M	Buy	19,353 +2,423	+14%	+$537K	0.85%	39
2025 Q4	$3.87M	Buy	16,930 +400	+2%	+$91.1K	0.88%	38
2025 Q3	$3.83M	Buy	16,530 +693	+4%	+$141K	0.83%	41
2025 Q2	$2.94M	Buy	+15,837	New	+$2.94M	0.71%	42
2024 Q4	–	Sell	-12	Closed	-$342K	–	124
2024 Q3	$342K	Sell	12 -1,695	-99%	-$316K	0.08%	95
2024 Q2	$293K	Buy	1,707 +328	+24%	+$54.3K	0.07%	96
2024 Q1	$251K	Sell	1,379 -24,553	-95%	-$4.23M	0.07%	100
2023 Q4	$4.25M	Buy	25,932 +24,541	+1,764%	+$3.58M	1.35%	23
2023 Q3	$203K	Buy	+1,391	New	+$204K	0.16%	46
2023 Q2	–	Sell	-1,479	Closed	-$236K	–	42
2023 Q1	$236K	Sell	1,479 -25,367	-94%	-$3.88M	0.21%	43
2022 Q4	$4.08M	Buy	26,846 +25,367	+1,715%	+$3.89M	2.36%	11
2022 Q3	$214K	Buy	1,479 +687	+87%	+$98.6K	0.11%	81
2022 Q2	$107K	Sell	792 -687	-46%	-$105K	0.04%	119
2022 Q1	$208K	Buy	1,479 +687	+87%	+$99.8K	0.1%	87
2021 Q4	$107K	Buy	+792	New	+$93.6K	0.04%	119

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Scissortail Wealth Management's ABBV Position: Q1 2026 in Review

Scissortail Wealth Management increased its AbbVie (ABBV) stake by 14% in Q1 2026, buying an estimated $537K and bringing the position to 19,353 shares worth $4.21M. The position accounts for 0.85% of the portfolio, ranked #39.

Scissortail Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 15 quarters since. The position peaked at $4.25M in Q4 2023. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Scissortail Wealth Management held 19,353 shares of AbbVie worth $4.21M as of Q1 2026.
Scissortail Wealth Management bought 2,423 AbbVie shares in Q1 2026, an estimated $537K.
AbbVie made up 0.85% of Scissortail Wealth Management's portfolio in Q1 2026, its #39 holding.
Scissortail Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 15 quarters since.
Scissortail Wealth Management's AbbVie position peaked at $4.25M in Q4 2023.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Scissortail Wealth Management's 13F filing for Q1 2026, filed 23 Apr 2026.